// App-Quantinova.ai

4575 : Altered catalytic properties of a subset of Met cytoplasmic domain variants occurring in renal cell carcinoma

Researchers

Presenter

  • Dinuka De Silva

Principal Investigators

  • Young Lee

  • Arpita Roy

  • Donald P. Bottaro

Medical Centers

  • NIH/NIMHD, Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Renal cell carcinoma

  • Clear cell renal carcinoma

  • Solid malignancies

Biomarkers

  • Cyclic AMP-dependent protein kinase

  • Hepatocyte growth factor

  • MET proto-oncogene, receptor tyrosine kinase

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved